Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Sep 28, 2024
Revenue increased slightly in the quarter, reversing the downward trend seen in the prior periods. The improvement was small relative to both the preceding quarter and the same quarter one year earlier.
Key takeaway
Quarter ended Sep 28, 2024 · FY2024 Q3
Revenue increased slightly in the quarter, reversing the downward trend seen in the prior periods. The improvement was small relative to both the preceding quarter and the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.6B
Revenue reported for this quarter.
Quarter-over-quarter
+0.5%
Change from the immediately preceding quarter.
Year-over-year
+0.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$42.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $10.9B | -4.9% |
| Mar 30, 2024 | $10.3B | -3.4% |
| Jun 29, 2024 | $10.5B | -1.4% |
| Sep 28, 2024 | $10.6B | +0.2% |
Revenue performance
The reported revenue for the quarter reflects a modest sequential uptick. Compared with the same quarter last year, revenue was marginally higher.
Quarterly comparison
Sequentially, revenue increased from the immediately preceding quarter. On a year-over-year basis, revenue also grew, though the pace of growth remained subdued.
What to watch
The filing context does not provide commentary on revenue drivers; no specific watch items are supported by the supplied data.